๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Histone deacetylase inhibitors: Potential in cancer therapy

โœ Scribed by P.A. Marks; W.-S. Xu

Book ID
111700575
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
170 KB
Volume
107
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Targeting Histone Deacetylase in Cancer
Targeting Histone Deacetylase in Cancer Therapy
โœ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons โš– 8 KB ๐Ÿ‘ 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Targeting histone deacetylase in cancer
Targeting histone deacetylase in cancer therapy
โœ Hsiang-Yu Lin; Chang-Shi Chen; Shuan-Pei Lin; Jing-Ru Weng; Ching-Shih Chen ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB

## Abstract Histone deacetylase (HDAC) is recognized as one of the promising targets for cancer treatment as many HDAC inhibitors have entered clinical trials for both solid and liquid tumors. Nevertheless, the mechanisms underlying the antiproliferative effects of HDAC inhibitors remain elusive. A